{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:36:06Z","timestamp":1793824566929,"version":"4.6.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPD1G0141-3"],"award-info":[{"award-number":["CMRPD1G0141-3"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPD1I0151-2"],"award-info":[{"award-number":["CMRPD1I0151-2"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPD1G0141-3"],"award-info":[{"award-number":["CMRPD1G0141-3"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPD1I0151-2"],"award-info":[{"award-number":["CMRPD1I0151-2"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["CMRPD1G0141-3"],"award-info":[{"award-number":["CMRPD1G0141-3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["CMRPD1I0151-2"],"award-info":[{"award-number":["CMRPD1I0151-2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.coi.2021.05.007","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T22:38:23Z","timestamp":1624574303000},"page":"206-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"special_numbering":"C","title":["Anti-interferon-\u03b3 autoantibody-associated immunodeficiency"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2247-5467","authenticated-orcid":false,"given":"Han-Po","family":"Shih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5092-7774","authenticated-orcid":false,"given":"Jing-Ya","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Fu","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1425-8585","authenticated-orcid":false,"given":"Chih-Yu","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Lung","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2021.05.007_bib0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev-immunol-032713-120222","article-title":"Anticytokine autoantibody-associated immunodeficiency","volume":"32","author":"Browne","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coi.2021.05.007_bib0010","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00439-020-02180-0","article-title":"Autoantibodies against cytokines: phenocopies of primary immunodeficiencies?","volume":"139","author":"Ku","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.coi.2021.05.007_bib0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4049\/jimmunol.144.2.685","article-title":"Natural antibodies to IFN-gamma in man and their increase during viral infection","volume":"144","author":"Caruso","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.05.007_bib0020","first-page":"611","article-title":"Individuals infected with HIV possess antibodies against IL-2","volume":"65","author":"Bost","year":"1988","journal-title":"Immunology"},{"key":"10.1016\/j.coi.2021.05.007_bib0025","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.coi.2009.09.004","article-title":"Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages","volume":"21","author":"Trapnell","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2021.05.007_bib0030","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.190.6.875","article-title":"Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte\/macrophage colony-stimulating factor","volume":"190","author":"Kitamura","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.05.007_bib0035","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1056\/NEJMc0904077","article-title":"Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis","volume":"361","author":"Sakagami","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2021.05.007_bib0040","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20091983","article-title":"Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I","volume":"207","author":"Puel","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.05.007_bib0045","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","article-title":"Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines","volume":"207","author":"Kisand","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.05.007_bib0050","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/art.39607","article-title":"Distinct functions of autoantibodies against interferon in systemic lupus erythematosus: a comprehensive analysis of anticytokine autoantibodies in common rheumatic diseases","volume":"68","author":"Gupta","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2021.05.007_sbref0055","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coi.2021.05.007_sbref0060","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202486","article-title":"Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine","volume":"218","author":"Bastard","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.05.007_bib0065","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.4049\/jimmunol.1202526","article-title":"Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis","volume":"190","author":"Rosen","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.05.007_bib0070","doi-asserted-by":"crossref","first-page":"e00912","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients","volume":"5","author":"Saijo","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.coi.2021.05.007_bib0075","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4049\/jimmunol.180.1.647","article-title":"Recurrent Staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6","volume":"180","author":"Puel","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.05.007_sbref0080","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1086\/380453","article-title":"Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity","volume":"38","author":"Doffinger","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2021.05.007_sbref0085","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2003-04-1065","article-title":"Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans","volume":"103","author":"Hoflich","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.05.007_sbref0090","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI19316","article-title":"Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma","volume":"115","author":"Kampmann","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2021.05.007_sbref0095","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.4049\/jimmunol.175.7.4769","article-title":"Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections","volume":"175","author":"Patel","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2021.05.007_bib0100","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.cell.2020.10.046","article-title":"Human T-bet governs innate and innate-like adaptive IFN-gamma immunity against mycobacteria","volume":"183","author":"Yang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.coi.2021.05.007_bib0105","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1172\/JCI135460","article-title":"Inherited human IFN-gamma deficiency underlies mycobacterial disease","volume":"130","author":"Kerner","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2021.05.007_sbref0110","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00439-020-02120-y","article-title":"Mendelian susceptibility to mycobacterial disease: recent discoveries","volume":"139","author":"Bustamante","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.coi.2021.05.007_bib0115","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1182\/blood-2013-01-474213","article-title":"Autoantibodies against cytokines: back to human genetics","volume":"121","author":"Puel","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.05.007_sbref0120","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1111160","article-title":"Adult-onset immunodeficiency in Thailand and Taiwan","volume":"367","author":"Browne","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2021.05.007_sbref0125","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1182\/blood-2012-08-452482","article-title":"Anti-IFN-gamma autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection","volume":"121","author":"Chi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.05.007_sbref0130","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/cid\/cix996","article-title":"Clinical significance of interferon-gamma neutralizing autoantibodies against disseminated nontuberculous mycobacterial disease","volume":"66","author":"Aoki","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2021.05.007_sbref0135","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190502","article-title":"Anti-IFN-gamma autoantibodies underlie disseminated Talaromyces marneffei infections","volume":"217","author":"Guo","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2021.05.007_bib0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076371","article-title":"Autoantibody to interferon-gamma associated with adult-onset immunodeficiency in non-HIV individuals in Northern Thailand","volume":"8","author":"Wongkulab","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2021.05.007_bib0145","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003927","article-title":"Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-gamma autoantibodies and disseminated nontuberculous mycobacterial infections","volume":"95","author":"Chi","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.coi.2021.05.007_bib0150","doi-asserted-by":"crossref","first-page":"1684 e1681","DOI":"10.1016\/j.cmi.2020.02.030","article-title":"Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies","volume":"26","author":"Wu","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.coi.2021.05.007_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215581","article-title":"Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-gamma autoantibodies","volume":"14","author":"Angkasekwinai","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2021.05.007_bib0160","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/1535370218764086","article-title":"Characterization of anti-interferon-gamma antibodies in HIV-negative immunodeficient patients infected with unusual intracellular microorganisms","volume":"243","author":"Wipasa","year":"2018","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.coi.2021.05.007_sbref0165","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s10875-019-00652-1","article-title":"Juvenile-onset immunodeficiency secondary to anti-interferon-gamma autoantibodies","volume":"39","author":"Liew","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.05.007_bib0170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s15010-010-0067-3","article-title":"Anti-interferon-gamma autoantibody and opportunistic infections: case series and review of the literature","volume":"39","author":"Kampitak","year":"2011","journal-title":"Infection"},{"key":"10.1016\/j.coi.2021.05.007_bib0175","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/MD.0b013e3181fdd832","article-title":"Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countries","volume":"89","author":"de Beaucoudrey","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.coi.2021.05.007_bib0180","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","article-title":"Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity","volume":"26","author":"Bustamante","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.coi.2021.05.007_sbref0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000347112","article-title":"Reactive and infective dermatoses associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibody: sweet\u2019s syndrome and beyond","volume":"226","author":"Chan","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.coi.2021.05.007_bib0190","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2340\/00015555-2959","article-title":"Skin manifestations in patients with adult-onset immunodeficiency due to anti-interferon-gamma autoantibody: a relationship with systemic infections","volume":"98","author":"Jutivorakool","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.coi.2021.05.007_bib0195","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jaad.2017.11.064","article-title":"Neutrophilic dermatoses: pathogenesis, sweet syndrome, neutrophilic eccrine hidradenitis, and Behcet disease","volume":"79","author":"Nelson","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coi.2021.05.007_sbref0200","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1128\/CVI.00053-10","article-title":"Disseminated penicilliosis, recurrent bacteremic nontyphoidal salmonellosis, and burkholderiosis associated with acquired immunodeficiency due to autoantibody against gamma interferon","volume":"17","author":"Tang","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.coi.2021.05.007_bib0205","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1128\/CMR.19.1.95-110.2006","article-title":"Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects","volume":"19","author":"Vanittanakom","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.coi.2021.05.007_bib0210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/QCO.0b013e3282f406ae","article-title":"Penicillium marneffei infection in HIV","volume":"21","author":"Ustianowski","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.coi.2021.05.007_bib0215","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.3389\/fimmu.2019.02189","article-title":"Application of flow cytometry in the diagnostics pipeline of primary immunodeficiencies underlying disseminated Talaromyces marneffei infection in HIV-negative children","volume":"10","author":"Lee","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2021.05.007_bib0220","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10875-015-0161-5","article-title":"Late-onset disseminated Mycobacterium avium intracellulare complex infection (MAC), cerebral toxoplasmosis and salmonella sepsis in a German caucasian patient with unusual anti-interferon-gamma IgG1 autoantibodies","volume":"35","author":"Hanitsch","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.05.007_bib0225","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.autrev.2005.10.012","article-title":"The genetic basis of autoantibody production","volume":"5","author":"Reveille","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.coi.2021.05.007_sbref0230","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaci.2015.09.018","article-title":"Anti-IFN-gamma autoantibodies are strongly associated with HLA-DR*15:02\/16:02 and HLA-DQ*05:01\/05:02 across Southeast Asia","volume":"137","author":"Ku","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2021.05.007_bib0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128481","article-title":"HLA-DRB1 and HLA-DQB1 are associated with adult-onset immunodeficiency with acquired anti-interferon-gamma autoantibodies","volume":"10","author":"Pithukpakorn","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2021.05.007_bib0240","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03236-5","article-title":"Genomic insights into population history and biological adaptation in Oceania","volume":"592","author":"Choin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.coi.2021.05.007_sbref0245","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/nm.4158","article-title":"Identification of a major epitope by anti-interferon-gamma autoantibodies in patients with mycobacterial disease","volume":"22","author":"Lin","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2021.05.007_bib0250","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/protein\/4.3.335","article-title":"The carboxyl-terminal region of human interferon gamma is important for biological activity: mutagenic and NMR analysis","volume":"4","author":"Lundell","year":"1991","journal-title":"Protein Eng"},{"key":"10.1016\/j.coi.2021.05.007_bib0255","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cytogfr.2009.02.006","article-title":"Structural conservation of interferon gamma among vertebrates","volume":"20","author":"Savan","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.coi.2021.05.007_bib0260","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1021\/bi00406a026","article-title":"Evidence for a polypeptide segment at the carboxyl terminus of recombinant human gamma interferon involved in expression of biological activity","volume":"27","author":"Seelig","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/j.coi.2021.05.007_bib0265","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jiac.2013.08.003","article-title":"Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients","volume":"20","author":"Shima","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.coi.2021.05.007_sbref0270","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/cid\/cix372","article-title":"Repurposing QuantiFERON for detection of neutralizing interferon-gamma autoantibodies in patients with nontuberculous mycobacterial infections","volume":"65","author":"Suarez","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2021.05.007_sbref0275","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cmi.2017.06.029","article-title":"Use of QuantiFERON-TB gold in-tube assay in screening for neutralizing anti-interferon-gamma autoantibodies in patients with disseminated nontuberculous mycobacterial infection","volume":"24","author":"Wu","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.coi.2021.05.007_bib0280","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1086\/605581","article-title":"Recurrent, multifocal Mycobacterium avium-intercellulare infection in a patient with interferon-gamma autoantibody","volume":"49","author":"Baerlecken","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2021.05.007_bib0285","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s10156-008-0662-8","article-title":"Anti-interferon-gamma autoantibody in a patient with disseminated Mycobacterium avium complex","volume":"15","author":"Koya","year":"2009","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.coi.2021.05.007_sbref0290","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1182\/blood-2011-12-395707","article-title":"Anti-CD20 (rituximab) therapy for anti-IFN-gamma autoantibody-associated nontuberculous mycobacterial infection","volume":"119","author":"Browne","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.coi.2021.05.007_bib0295","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1093\/cid\/cit809","article-title":"Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-gamma autoantibody","volume":"58","author":"Czaja","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2021.05.007_bib0300","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw093","article-title":"Disseminated Talaromyces marneffei and Mycobacterium abscessus in a patient with anti-interferon-gamma autoantibodies","volume":"3","author":"Pruetpongpun","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.coi.2021.05.007_bib0305","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s10875-017-0425-3","article-title":"Rituximab restores IFN-gamma-STAT1 function and ameliorates disseminated Mycobacterium avium infection in a patient with anti-interferon-gamma autoantibody","volume":"37","author":"Koizumi","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2021.05.007_bib0310","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6473629","article-title":"Intravenous cyclophosphamide therapy for anti-IFN-gamma autoantibody-associated Mycobacterium abscessus infection","volume":"2018","author":"Chetchotisakd","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.coi.2021.05.007_bib0315","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa035","article-title":"Prospective pilot study of cyclophosphamide as an adjunct treatment in patients with adult-onset immunodeficiency associated with anti-interferon-gamma autoantibodies","volume":"7","author":"Laisuan","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.coi.2021.05.007_bib0320","article-title":"Daratumumab (anti-CD38) for treatment of disseminated nontuberculous mycobacteria in a patient with anti-IFN-gamma autoantibodies","author":"Ochoa","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2021.05.007_bib0325","first-page":"53","article-title":"Resetting the immune system with immunoablation and autologous haematopoietic stem cell transplantation in autoimmune diseases","volume":"34","author":"Alexander","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.coi.2021.05.007_bib0330","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0961203312470729","article-title":"Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European group for blood and marrow transplantation registry","volume":"22","author":"Alchi","year":"2013","journal-title":"Lupus"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791521000650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791521000650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:49:22Z","timestamp":1760604562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791521000650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":66,"alternative-id":["S0952791521000650"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2021.05.007","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-interferon-\u03b3 autoantibody-associated immunodeficiency","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2021.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}